These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9539581)

  • 61. Monte Carlo-aided dosimetry of the Symmetra model I25.S06 125I, interstitial brachytherapy seed.
    Hedtjärn H; Carlsson GA; Williamson JF
    Med Phys; 2000 May; 27(5):1076-85. PubMed ID: 10841412
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Verification of air-kerma strength of 125I seed for permanent prostate implants in Japan.
    Sumida I; Koizumi M; Takahashi Y; Ogata T; Akino Y; Isohashi F; Konishi K; Yoshioka Y; Inoue T
    Int J Clin Oncol; 2009 Dec; 14(6):525-8. PubMed ID: 19967489
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Coupling I-125 permanent implant prostate brachytherapy Monte Carlo dose calculations with radiobiological models.
    Miksys N; Haidari M; Vigneault E; Martin AG; Beaulieu L; Thomson RM
    Med Phys; 2017 Aug; 44(8):4329-4340. PubMed ID: 28455849
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Limitations of the minimum peripheral dose as a parameter for dose specification in permanent 125I prostate implants.
    Yu Y; Waterman FM; Suntharalingam N; Schulsinger A
    Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):717-25. PubMed ID: 8621297
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of dose length, area, and volume histograms as quantifiers of urethral dose in prostate brachytherapy.
    Butler WM; Merrick GS; Dorsey AT; Hagedorn BM
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1575-82. PubMed ID: 11121664
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of prostatic edema on CT-based postimplant dosimetry.
    Dogan N; Mohideen N; Glasgow GP; Keys K; Flanigan RC
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):483-9. PubMed ID: 12023153
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Guidance to users of Nycomed Amersham and North American Scientific, Inc., I-125 interstitial sources: dosimetry and calibration changes: recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-Energy Seed Dosimetry.
    Williamson JF; Coursey BM; DeWerd LA; Hanson WF; Nath R; Ibbott G
    Med Phys; 1999 Apr; 26(4):570-3. PubMed ID: 10227361
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition.
    Waterman FM; Yue N; Corn BW; Dicker AP
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1069-77. PubMed ID: 9719117
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prostate brachytherapy in patients with prostate volumes >/= 50 cm(3): dosimetic analysis of implant quality.
    Stone NN; Stock RG
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1199-204. PubMed ID: 10725632
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The coupling of anisotropy and radial dose functions for 103Pd and 125I for use with a commercial treatment planning system.
    Prete JJ; Bice WS; Dubois DF; Prestidge BR
    Med Phys; 1997 Apr; 24(4):523-5. PubMed ID: 9127302
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Procedures for establishing and maintaining consistent air-kerma strength standards for low-energy, photon-emitting brachytherapy sources: recommendations of the Calibration Laboratory Accreditation Subcommittee of the American Association of Physicists in Medicine.
    DeWerd LA; Huq MS; Das IJ; Ibbott GS; Hanson WF; Slowey TW; Williamson JF; Coursey BM;
    Med Phys; 2004 Mar; 31(3):675-81. PubMed ID: 15070265
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Correlation between pre- and postimplant dosimetry for iodine-125 seed implants for localized prostate cancer.
    Al-Qaisieh B; Witteveen T; Carey B; Henry A; Bottomley D; Smith J; Franks K; Bownes P
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):626-30. PubMed ID: 19540077
    [TBL] [Abstract][Full Text] [Related]  

  • 73. On the sensitivity of α/β prediction to dose calculation methodology in prostate brachytherapy.
    Afsharpour H; Walsh S; Collins Fekete CA; Vigneault E; Verhaegen F; Beaulieu L
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):345-50. PubMed ID: 24411607
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The impact of hormone therapy on post-implant dosimetry and outcome following Iodine-125 implant monotherapy for localised prostate cancer.
    Ash D; Al-Qaisieh B; Bottomley D; Carey B; Joseph J
    Radiother Oncol; 2005 Jun; 75(3):303-6. PubMed ID: 15890423
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prescription dose in permanent (131)Cs seed prostate implants.
    Yue N; Heron DE; Komanduri K; Huq MS
    Med Phys; 2005 Aug; 32(8):2496-502. PubMed ID: 16193779
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Some treatment planning considerations for 103Pd and 125I permanent interstitial implants.
    Nath R; Meigooni AS; Melillo A
    Int J Radiat Oncol Biol Phys; 1992; 22(5):1131-8. PubMed ID: 1555965
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Experimental measurements of dosimetric parameters on the transverse axis of a new 125I source.
    Li Z; Fan JJ; Palta JR
    Med Phys; 2000 Jun; 27(6):1275-80. PubMed ID: 10902556
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The recommendations of the International Commission on Radiological Protection (ICRP) for high-dose-rate brachytherapy and for permanent prostatic implants].
    Cosset JM; Pinillos-Ashton L; Mettler F;
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S50-5. PubMed ID: 15679247
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
    Chibani O; Williamson JF; Todor D
    Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.